Tama Dinur

1.9k total citations
64 papers, 1.3k citations indexed

About

Tama Dinur is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Tama Dinur has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Physiology, 31 papers in Molecular Biology and 24 papers in Organic Chemistry. Recurrent topics in Tama Dinur's work include Lysosomal Storage Disorders Research (51 papers), Carbohydrate Chemistry and Synthesis (24 papers) and Cellular transport and secretion (22 papers). Tama Dinur is often cited by papers focused on Lysosomal Storage Disorders Research (51 papers), Carbohydrate Chemistry and Synthesis (24 papers) and Cellular transport and secretion (22 papers). Tama Dinur collaborates with scholars based in Israel, United States and Germany. Tama Dinur's co-authors include Shimon Gátt, Robert J. Desnick, Gregory A. Grabowski, Ari Zimran, G. Legler, Shoshana Revel‐Vilk, S Gatt, Y. Barenholz, Michal Becker‐Cohen and Arndt Rolfs and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Tama Dinur

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tama Dinur Israel 22 859 643 416 308 156 64 1.3k
Richie Khanna United States 22 1.1k 1.3× 799 1.2× 478 1.1× 495 1.6× 380 2.4× 39 1.7k
Nick Dekker Netherlands 18 683 0.8× 557 0.9× 338 0.8× 223 0.7× 279 1.8× 21 1.1k
Alexander V. Skurat United States 23 381 0.4× 798 1.2× 216 0.5× 189 0.6× 82 0.5× 37 1.5k
Ryan D. Martinus New Zealand 18 869 1.0× 1.0k 1.6× 447 1.1× 82 0.3× 189 1.2× 28 1.6k
Daniel Sevlever United States 16 403 0.5× 389 0.6× 250 0.6× 77 0.3× 369 2.4× 31 1.1k
Fannie W. Chen United States 11 510 0.6× 380 0.6× 222 0.5× 153 0.5× 121 0.8× 12 937
Yunxiang Zhu United States 22 482 0.6× 1.0k 1.6× 578 1.4× 131 0.4× 159 1.0× 43 1.7k
Arie Oosterhof Netherlands 21 113 0.1× 871 1.4× 450 1.1× 99 0.3× 91 0.6× 55 1.2k
Marian A. Kroos Netherlands 36 2.8k 3.3× 1.0k 1.6× 384 0.9× 1.2k 3.9× 577 3.7× 88 3.6k
Cristin Davidson United States 17 969 1.1× 436 0.7× 247 0.6× 271 0.9× 256 1.6× 28 1.5k

Countries citing papers authored by Tama Dinur

Since Specialization
Citations

This map shows the geographic impact of Tama Dinur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tama Dinur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tama Dinur more than expected).

Fields of papers citing papers by Tama Dinur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tama Dinur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tama Dinur. The network helps show where Tama Dinur may publish in the future.

Co-authorship network of co-authors of Tama Dinur

This figure shows the co-authorship network connecting the top 25 collaborators of Tama Dinur. A scholar is included among the top collaborators of Tama Dinur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tama Dinur. Tama Dinur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zimran, Ari, Shoshana Revel‐Vilk, Tama Dinur, et al.. (2025). Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey. Orphanet Journal of Rare Diseases. 20(1). 43–43. 2 indexed citations
3.
Frydman, Dafna, et al.. (2023). High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction Therapy. International Journal of Molecular Sciences. 24(7). 6732–6732. 10 indexed citations
4.
Becker‐Cohen, Michal, Shoshana Revel‐Vilk, Dafna Frydman, et al.. (2023). Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease. Internal Medicine Journal. 54(3). 398–403. 4 indexed citations
5.
Becker‐Cohen, Michal, Ari Zimran, Tama Dinur, et al.. (2022). A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease—Identifying Those at the Greatest Risk. International Journal of Molecular Sciences. 23(20). 12211–12211. 6 indexed citations
6.
Dinur, Tama, Ulrike Grittner, Shoshana Revel‐Vilk, et al.. (2021). Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations. International Journal of Molecular Sciences. 22(14). 7699–7699. 19 indexed citations
7.
Revel‐Vilk, Shoshana, Dafna Frydman, Michael R. Freund, et al.. (2021). Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease. Thrombosis and Haemostasis. 122(6). 951–960. 7 indexed citations
8.
Dinur, Tama, Dafna Frydman, Michal Becker‐Cohen, et al.. (2020). Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease. Orphanet Journal of Rare Diseases. 15(1). 284–284. 14 indexed citations
9.
Arkadir, David, Tama Dinur, Shoshana Revel‐Vilk, et al.. (2019). Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA‐related Parkinson's disease. European Journal of Neurology. 26(7). 1013–1018. 12 indexed citations
10.
Sidransky, Ellen, David Arkadir, Peter Bauer, et al.. (2019). Substrate Reduction Therapy for GBA1‐Associated Parkinsonism: Are We Betting on the Wrong Mouse?. Movement Disorders. 35(2). 228–230. 12 indexed citations
11.
Dinur, Tama, Ari Zimran, Michal Becker‐Cohen, et al.. (2019). Long-term follow-up of 103 untreated adult patients with type 1 Gaucher disease. Molecular Genetics and Metabolism. 126(2). S49–S49. 1 indexed citations
12.
Dinur, Tama, et al.. (2016). Comparison of Bone Mineral Density by Dual-Energy X-Ray Absorptiometry and Bone Strength by Speed-of-Sound Ultrasonography in Adults With Gaucher Disease. Journal of Clinical Densitometry. 19(4). 465–470. 1 indexed citations
13.
Webb, Muriel, Ari Zimran, Tama Dinur, et al.. (2016). Are transient and shear wave elastography useful tools in Gaucher disease?. Blood Cells Molecules and Diseases. 68. 143–147. 19 indexed citations
14.
Arkadir, David, Tama Dinur, Stephen Mullin, et al.. (2016). Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations. Blood Cells Molecules and Diseases. 68. 115–116. 16 indexed citations
15.
Gátt, Shimon, Tama Dinur, & Arie Dagan. (2003). Liposome-Mediated, Fluorescence-Based Studies of Sphingolipid Metabolism in Intact Cells. Humana Press eBooks. 199. 85–106. 1 indexed citations
16.
Madar-Shapiro, Liora, et al.. (1999). Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators. Journal of Inherited Metabolic Disease. 22(5). 623–637. 6 indexed citations
17.
18.
Epstein, Michal, et al.. (1993). Diagnosing sphingolipidoses in murine and human embryos. Human Reproduction. 8(2). 302–309. 4 indexed citations
19.
Dinur, Tama, Edward H. Schuchman, Eitan Fibach, et al.. (1992). Toward Gene Therapy for Niemann-Pick Disease (NPD): Separation of Retrovirally Corrected and Noncorrected NPD Fibroblasts Using a Novel Fluorescent Sphingomyelin. Human Gene Therapy. 3(6). 633–639. 15 indexed citations
20.
Dinur, Tama, et al.. (1991). Administration of pyrene lipids by receptor-mediated endocytosis and their degradation in skin fibroblasts. Experimental Cell Research. 196(2). 151–157. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richie Khanna Breakdown of academic impact, for papers by Nick Dekker Breakdown of academic impact, for papers by Alexander V. Skurat Breakdown of academic impact, for papers by Ryan D. Martinus Breakdown of academic impact, for papers by Daniel Sevlever Breakdown of academic impact, for papers by Fannie W. Chen Breakdown of academic impact, for papers by Yunxiang Zhu Breakdown of academic impact, for papers by Arie Oosterhof Breakdown of academic impact, for papers by Marian A. Kroos Breakdown of academic impact, for papers by Cristin Davidson
Rankless by CCL
2026